Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. financial statements

Xilio Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 43.77M10-K
Net income−USD 35.04M10-K
Cash and equivalentsUSD 137.53M10-Q
Total debtUSD 6.95MEODHD

Xilio Therapeutics, Inc. financials on 6ix · Xilio Therapeutics, Inc. on 6ix